Fund Timeline From Launch to Harvesting - Search News

Order byBest matchMost fresh

News

6d

BioHarvest outlines path to $11M–$12M quarterly revenue for adjusted EBITDA breakeven while expanding VINIA portfolio and CDMO pipeline

Discover how BioHarvest Sciences achieved 47% revenue growth in Q1 2025, advanced CDMO milestones, and expanded into new product categories.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results